1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1619
  6. Examiner Greene

Examiner Greene Ivan A

1619-GREENE-IVAN-A

Employment Information

Art Unit:1619 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
504 — Plant protecting and regulating compositions
536 — Organic compounds -- part of the class 532-570 series
425 — Plastic article or earthenware shaping or treating: apparatus
604 — Surgery
528 — Synthetic resins or natural rubbers -- part of the class 520 series
428 — Stock material or miscellaneous articles
359 — Optical: systems and elements
106 — Compositions: coating or plastic
Phone:(571) 270-5868
Email:ivan.greene@uspto.gov
Location:VA 22314
Title:Pat Examnr Gen Chem
Service:18 years
Grade:GS-12

Grant Rate and Difficulty Ranking

95
3-Year Grant rate: 13% over 207 cases
Difficulty: Extremely Hard
Difficulty Percentile: 95th

With Examiner Greene, you have a 13% chance of getting an issued patent by 3 years after the first office action. Examiner Greene is an extremely hard examiner and in the 95th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Greene, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1619

Examiner Greene's grant rate is lower than that of Art Unit 1619 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Greene 2.2
Art Unit 1619 2.4

Interview Benefit

Grant Rate without Interview

Examiner Greene has granted 14 of 139 cases without any applicant-requested interviews for a grant rate of 10%.

Grant Rate with Interview

Examiner Greene has granted 13 of 68 cases with at least one applicant-requested interview for a grant rate of 19%.

Interview Benefit

With Examiner Greene, conducting an interview increases your chance of getting a patent granted by 90%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17749572 Magnetically-Aligned Synthetic Extracellular Matrix Fibers Within Hydrogel Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
16154881 Formulations And Carrier Systems Including Compound Interactive Domains Abandoned View
18348799 Extended Use Zirconium Silicate Compositions And Methods Of Use Thereof Patented View
17811296 Methods For Treatment Of Bladder Cancer With Gemcitabine Patented View
18025686 Microorganism Targeted Nanoformulations Comprising Antimicrobial Component(S) Abandoned View
18025408 Nanoparticles To Improve Analytical Signal Abandoned View
18020525 Active Agent Release Particle Abandoned View
17041094 Poly (Alkyl Cyanoacrylate) Nanoparticles For Use In Treatment Of Cancer Abandoned View
17926902 Composite Material Abandoned View
18001398 Nanosphere Size Control By Varying The Ratio Of Copolymer Blends Abandoned View
16652944 Water-Based Tissue Adhesives Patented View
17748197 Polymer Complex For Anticancer Immune Therapy Based On Ultrasound Comprising Oxalate Derivatives And Method Of Preparation Thereof Abandoned View
17827190 Light-Controllable Self-Assembled Complex And Nanosystem Including The Same Abandoned View
17786678 Determining Capsule Specificity For Specific Cell Types Abandoned View
17070311 Plasmonic Enhanced Magnetic Nanoparticles Hyperthermia Abandoned View
18016092 Veterinary Compositions For The Treatment And/or Prevention Of Protozoan Diseases And Methods Of Preparation Thereof Abandoned View
17332175 Poly(Amine-Co-Ester) Polymeric Particles For Selective Pulmonary Delivery Abandoned View
16825873 Multilayered Pharmaceutically Active Compound-Releasing Microparticles In A Liquid Dosage Form Patented View
16896259 Multi-Dose Concentrated Liquid Diphenhydramine Hcl Compositions And Packaged Multi-Dose Liquid Diphenhydramine Hcl Formulations Abandoned View
17999384 Method Of Treating Obesity-Induced Glucose Intolerance And Liver Fibrosis Abandoned View
18500167 Plasmonic Enhanced Magnetic Nanoparticles Hyperthermia Abandoned View
18071733 Nanoemulsion Abandoned View
17200540 Injectable Therapeutic Biocompatible Co-Polymers And Methods Of Making And Using Same Abandoned View
16061156 Topical Delivery System For Active Ingredients Abandoned View
17903273 Liquid Foundation Using Starch As Filler And Preparation Method Thereof Abandoned View
17627044 Alkalization Of Urinary Bladder Wall Prior To Treatment With Intravesical Heparin And Alkalinized Lidocaine To Enhance Relief Of Bladder Pain Symptoms Abandoned View
17383161 Compounds And Methods Useful For Treating Or Preventing Hematological Cancers Abandoned View
18024743 Lipid Nanoparticles Manufacturing Chip, Lipid Nanoparticles Manufacturing System Having The Same, And Lipid Nanoparticles Manufacturing Method Patented View
17893633 Hybrid Fragrance Encapsulate Formulation And Method For Using The Same Patented View
16659490 Antimicrobial Magnesium Hydroxide Nanoparticles As An Alternative To Cu Biocide For Crop Protection Abandoned View
17761057 Bisphosphonate Loaded Starch Nanoparticle Abandoned View
17800066 Amphiphilic Imiquimod-Grafted Lauryl Gamma-Polyglutamate And Use Thereof Abandoned View
17646670 High-Density And Short-Chain Peg Modified Nano-Sized Carriers And Their Uses Abandoned View
17855758 Microporous Zirconium Silicate For The Treatment Of Hyperkalemia Abandoned View
17760537 Hair Treatment Method Abandoned View
17741464 Antimicrobial Nano-Deliverant And Methods Abandoned View
17244828 Nanoparticle Delivery To A Target Tissue Abandoned View
17987391 Upconversion Nanoparticle, Hyaluronic Acid-Upconversion Nanoparticle Conjugate, And A Production Method Thereof Using A Calculation From First Principles Abandoned View
17821471 Biocompatible Photothermal Composition For Treatment Of Cancer And Skin Diseases Abandoned View
15748469 Immunostimulatory Nanocarrier Abandoned View
18343812 Cancer Treating Composition Containing Copper-Silver-Phosphate Nanoparticles Patented View
17318339 Multi-Coated Nanoparticles Comprising Multiple Coating Layers Of Chitosan And Polyglutamic Acid, Composition For Skin Care Comprising The Same And Method For Manufacturing The Same Patented View
15409379 Hypochlorite Formulations For Wound Healing Patented View
18220560 Composition For Treating Bone Loss Abandoned View
17604138 Method For Removing Biofilm Abandoned View
17768132 Superfine Compounds And Production Thereof Abandoned View
16906028 Hydrogel Inclusion Complex Including Physiologically Active Material Bound To Thermosensitive Poly(Phosphazene) By Host-Guest Interaction Using Beta-Cyclodextrin And Use Thereof Abandoned View
17205521 Method For Treatment Of Coronavirus Infection Abandoned View
18343803 Copper-Silver-Phosphate Nanoparticle Manufacturing Method Patented View
18545415 Saccharide-Based Oral Mucoadhesive Delivery System For Neurotrophic And Neuroprotective Compositions Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.